Venn Life Sciences wins new contracts

Venn Life Sciences has won two contracts to provide a number of clinical trial-management services across Europe.

Venn Life Sciences has won two contracts to provide a number of clinical trial-management services across Europe.

The first contract is with a global pharmaceutical company to conduct a Phase IV drug interaction study and the second is with a leading US biotech company to manage a multi-national study. The group said it could not name either of the companies due to confidentiality agreements.

The new deals, combined with other recent contract wins, will contribute €0.9m in additional revenue for the financial year to December 31st 2013.

Venn also announced it has opened a new office in the UK and has appointed Stewart Hulse as Vice President of Resourcing.

"These recent business wins and the expansion of our business are in line with our goals as set out earlier this year," Chief Executive Officer, Tony Richardson, said.

"We have targeted medical devices as a key growth area and the recent project win is a welcome endorsement of our capabilities. Securing preferred vendor status with top ten Pharma is a major achievement for a company of our current scale and reflects well on the robustness of our business."

RD

Recommended

Why it pays to face up to your investment mistakes
Investment strategy

Why it pays to face up to your investment mistakes

Buying stocks can be a complicated business. But selling stocks can be tricky, too – even if you sell for the right reasons. Max King explains how to …
17 Sep 2021
Share tips of the week – 17 September
Share tips

Share tips of the week – 17 September

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
17 Sep 2021
Royal Mail will deliver for investors – here's how to play it
Trading

Royal Mail will deliver for investors – here's how to play it

Royal Mail Group has found its feet in the past 18 months and looks cheap. Matthew Partridge looks at how to trade the shares.
14 Sep 2021
The times may be changing, but don’t change how you invest
Small cap stocks

The times may be changing, but don’t change how you invest

We are living in strange times. But the basics of investing remain the same: buy fairly-priced stocks that can provide an income. And there are few be…
13 Sep 2021

Most Popular

The times may be changing, but don’t change how you invest
Small cap stocks

The times may be changing, but don’t change how you invest

We are living in strange times. But the basics of investing remain the same: buy fairly-priced stocks that can provide an income. And there are few be…
13 Sep 2021
Two shipping funds to buy for steady income
Investment trusts

Two shipping funds to buy for steady income

Returns from owning ships are volatile, but these two investment trusts are trying to make the sector less risky.
7 Sep 2021
Should investors be worried about stagflation?
US Economy

Should investors be worried about stagflation?

The latest US employment data has raised the ugly spectre of “stagflation” – weak growth and high inflation. John Stepek looks at what’s going on and …
6 Sep 2021